Alintegimod is an investigational integrin inhibitor being studied in clinical trials as a research compound. It is a synthetic small molecule with a highly flexible structure containing multiple aromatic rings and ether linkages.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1378535-08-0
Valsartan
pharmaceutical raw material
Alanine Valsartan
pharmaceutical raw material
D-valsartan
pharmaceutical raw material
N-(1-oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-L-valine methyl ester
pharmaceutical raw material
2-[2-[2-[bis(thiophen-2-ylmethyl)carbamoyloxy]ethoxy]ethoxy]ethyl N,N-bis(thiophen-2-ylmethyl)carbamate
PSBCCRKKPBQYJK-UHFFFAOYSA-N
C1=CSC(=C1)CN(CC2=CC=CS2)C(=O)OCCOCCOCCOC(=O)N(CC3=CC=CS3)CC4=CC=CS4